HIGH-
ALTITUDE
ILLNESS:
MANAGEMEN
T APPROACH
KADEK ARI RUSMIATI
1971121003
INTRODUCTION
HIGH ALTITUDE : > 2500
M
High-altitude illness
Acute Mountain Sickness (AMS)
High altitude cerebral edema (HACE)
High-altitude Pulmonary Edema
(HAPE)
THE PATHOPHYSIOLOGY OF HIGH-
ALTITUDE ILLNESS
↑ ultraviolet radiation
↓ temperature and humidity
↓ barometric pressure and
partial pressure of oxygen
DEFINITIONS AND CLINIC ASPECTS
Acute mountain
sickness
Mild Moderate Severe
3-5 6-9 10-12
Without any neurological finding
CON’T : DEFINITIONS AND CLINIC ASPECTS
High- High-
altitude altitude
cerebral Medical Society pulmonary
edema Practice Guidelines for edema
the Prevention and Noncardiogenic
Treatment of Acute pulmonary edema
Altitude Illness: 2014
Update
moderate-severe
ECG
symptoms in AMS +
neurological findings Chest radiographs
(ataxia, severe lassitude, partial pressure of
alter mental status and
encephalopathy) arterial oxygen
PREVENTION
Preacclimatisation
Modifying the risk factors
specific to individual
Pharmacologic strategies
TREATMENT
AMS HACE HAPE
• Descent • Descent • Descent
• Symptomatic • Supplemental • Supplemental
treatment oxygen oxygen
• Acetazolamide • Portable
hyperbaric
chambers
• Continuous
positive airway
pressure
CONCLUSION
High altitudes, usually above 2500 m, travelers are faced with decreased
partial pressure of oxygen along with decreased barometric pressure.
Most common symptoms are headache, nausea/vomiting, light-headedness,
insomnia, and fatigue.
Prevention strategies have favorable than the treatment.
THANKYOU